Comments to China Food and Drug Administration (CFDA) on Technical Guidelines for the Stability Study in Formula Registration of Infant Formula Milk Powder (Trial Edition)

2017-02-20 | Beijing

The European Chamber submitted collated comments to China Food and Drug Administration (CFDA) on Technical Guidelines for the Stability Study in Formula Registration of Infant Formula Milk Powder (Trial Edition) . The comments underlined the following aspects:

  1. The necessity of extending the grace period for the recipe registration of infant formula milk powder due to the new regulations on stability test;
  2. The significance on strengening the main responsibility of enteriprises on their own production ;
  3. The inconsistency of the stability test standards with the current practices.